Our Mission
AMYNO was founded on a single principle: researchers deserve complete confidence in the compounds they work with. Too often, peptide suppliers obscure quality data behind vague "purity claims" with no third-party verification. We built AMYNO to change that.
Every batch we ship is manufactured in GMP-certified facilities operating under ISO 9001 and ISO 13485 quality management systems — the same standards applied in pharmaceutical production. Every step of the synthesis process follows validated procedures aligned with FDA, EMA, and TGA regulatory frameworks.
We provide a full Certificate of Analysis with every order, documenting six quality parameters: HPLC purity, mass spectrometry identity confirmation, peptide content, endotoxin levels, heavy metal content, and total bioburden. All limits comply with current European Pharmacopoeia standards — not industry estimates.